EXPLEOSOLFinancial ResultsBSE
Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half - Year Ended September 30, 2026.
Filed 5 November 2026 at 5:37 am · 2h ago
FILING SUBJECT
Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half - Year Ended September 30, 2026.